Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Cattell

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Expert Opinion on Pharmacotherapy|May 31, 2002
Assessing outcomes in palliative chemotherapyEmma Cattell, Ana Arance, Mark Middleton
Environmental and Molecular Mutagenesis|February 23, 2010
The SNM1/Pso2 family of ICL repair nucleases: from yeast to manEmma Cattell, Blanka Sengerová, Peter J McHugh
Seminars in Oncology|October 31, 2002
Brain metastases in melanoma: a European perspectiveEmma Cattell, Charles Kelly, Mark R Middleton
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
A randomized phase II pharmacokinetic and pharmacodynamic study of indisulam as second-line therapy in patients with advanced non-small cell lung cancerDenis C Talbot, Joachim von Pawel, Emma Cattell, et al.
Genes & Development|September 8, 2011
Human SNM1A and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repairAnderson T Wang, Blanka Sengerová, Emma Cattell, et al.
Science Translational Medicine|July 16, 2010
Quinone oxidoreductase-2-mediated prodrug cancer therapyMark R Middleton, Richard Knox, Emma Cattell, et al.
JAMA Oncology|December 22, 2022
Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional EvaluationLennard Y W Lee, Michael Tilby, Thomas Starkey, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Expert Opinion on Pharmacotherapy|May 31, 2002
Assessing outcomes in palliative chemotherapyEmma Cattell, Ana Arance, Mark Middleton
Environmental and Molecular Mutagenesis|February 23, 2010
The SNM1/Pso2 family of ICL repair nucleases: from yeast to manEmma Cattell, Blanka Sengerová, Peter J McHugh
Seminars in Oncology|October 31, 2002
Brain metastases in melanoma: a European perspectiveEmma Cattell, Charles Kelly, Mark R Middleton
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
A randomized phase II pharmacokinetic and pharmacodynamic study of indisulam as second-line therapy in patients with advanced non-small cell lung cancerDenis C Talbot, Joachim von Pawel, Emma Cattell, et al.
Genes & Development|September 8, 2011
Human SNM1A and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repairAnderson T Wang, Blanka Sengerová, Emma Cattell, et al.
Science Translational Medicine|July 16, 2010
Quinone oxidoreductase-2-mediated prodrug cancer therapyMark R Middleton, Richard Knox, Emma Cattell, et al.
JAMA Oncology|December 22, 2022
Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional EvaluationLennard Y W Lee, Michael Tilby, Thomas Starkey, et al.
Pageof 1